SCHEMBL9765998

SCHEMBL9765998

Fc1ccc(SCCCN2CCN(c3ncc(F)cn3)CC2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 1.00
DRD2 P14416 7/20 0.81
DRD3 P35462 6/20 0.81
HTR1A P08908 5/20 0.81
HTR2A P28223 5/20 0.81
DRD1 P21728 4/20 0.81
DRD5 P21918 4/20 0.81
HRH1 P35367 2/20 0.65
ADRA2C P18825 1/20 0.65
HTR7 P34969 1/20 0.65
KDM4E B2RXH2 1/20 0.60
CYP1A2 P05177 1/20 0.60
GAA P10253 1/20 0.60
CYP2C9 P11712 1/20 0.60
TMEM97 Q5BJF2 1/20 0.60
HTR2C P28335 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9766026 0.81 SIGMAR1 (1.00) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL11870245 0.78 DRD2 (0.76) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL9765984 0.78 SIGMAR1 (1.00) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL9602967 0.76 SIGMAR1 (0.79) SIGMAR1DRD2KDM4ECYP1A2GAA
SCHEMBL9766043 0.76 SIGMAR1 (0.82) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL7386166 0.76 DRD2 (0.60) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL7855443 0.76 SIGMAR1 (0.63) SIGMAR1DRD2HTR1AKDM4ECYP1A2
SCHEMBL11868520 0.75 DRD2 (0.64) SIGMAR1DRD2DRD3HTR1AHTR2A
Bmy-14802 SCHEMBL467229 0.75 SIGMAR1 (1.00) SIGMAR1DRD2DRD3KDM4ECYP1A2
Bmy-14802 SCHEMBL8457738 0.75 SIGMAR1 (1.00) SIGMAR1DRD2DRD3KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US claimed
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP claimed
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US disclosed
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP disclosed